Gynecologic Cancer
Conference Coverage
Disproportionately low U.S. research funding targets gynecologic cancers
NEW ORLEANS – National Cancer Institute research funding for gynecologic cancers during 2007-2014 fell way short of several other cancer types.
Conference Coverage
VIDEO: Indocyanine green finds more sentinel lymph nodes
NEW ORLEANS – Indocyanine green surpassed isosulfan blue for mapping sentinel lymph nodes in stage I endometrial or cervical cancer in pivotal...
Conference Coverage
Trastuzumab plus chemo shows efficacy for high HER2 endometrial cancer
NEW ORLEANS – Combining trastuzumab with carboplatin and paclitaxel led to substantial responses in uterine serous carcinoma with high HER2 levels...
Conference Coverage
Residual single-site ovarian cancer surpasses multisite outcomes
NEW ORLEANS – If complete resection isn’t possible, patients with single-site residual disease do better than those with multisite residual tumors...
Conference Coverage
VIDEO: Interventions target opioid overprescribing after gynecologic surgery
NEW ORLEANS – Two studies document opioid overprescribing after gynecologic surgery and introduce interventions to address the problem.
Conference Coverage
VIDEO: Cervical cancer laparotomy outperforms minimally invasive surgery
NEW ORLEANS – Results showed open radical hysterectomy for early cervical cancer outperformed minimally invasive surgery.
Conference Coverage
Study: No increased risk of serious AEs with combined urogyn/gyn onc surgery
ORLANDO – Concurrent urogynecologic/gynecologic oncology surgery does not increase the risk of adverse events and should be offered to appropriate...
Conference Coverage
Combined PARP, checkpoint inhibitor regimens show ovarian cancer activity
Good responses were found in the first two reports on treatment of ovarian cancer patients with combined a PARP inhibitor and an immune checkpoint...
From the Journals
Oncologist-led BRCA mutation testing and counseling may reduce wait times for women with ovarian cancer
The median turnaround time from initial counseling to receiving a test result was 9.1 weeks.
Conference Coverage
VIDEO: Pelvic radiation surpasses brachytherapy/chemo for early endometrial cancer
Pelvic radiation produced similar recurrence-free survival as vaginal brachytherapy plus chemo but with less toxicity and fewer local recurrences...
Conference Coverage
VIDEO: Everolimus/letrozole promising for recurrent endometrial cancer
NEW ORLEANS – Phase 2 results show unexpectedly high efficacy for everolimus/letrozole in chemotherapy-naive...